Relay Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Relay Therapeutics Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Cambridge
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: RLAY
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001812364
Wikidata ID: Q106411735

Board of directors

Follow this board

Alexis Borisy · Director Overboarded
Since 2023
Claire Mazumdar · Director
Since 2025
Douglas S. Ingram · Director
Since 2023
Habib J. Dable · Director Overboarded
Since 2025
Jami Rubin · Director
Since 2023
Laura Shawver · Director
Since 2023
Linda A. Hill · Director
Since 2023
Lonnel Coats · Director
Since 2025
Mark Murcko · Director
Since 2023
Sanjiv Patel · Director · President and CEO
Since 2023
Sekar Kathiresan · Director
Since 2023

Chief executives

Sanjiv Patel · President and CEO

Dates unknown

Director election results

Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Douglas S. Ingram

82.2%
Claire Mazumdar

83.6%

Board connections

7 of this board's directors also sit on 15 other boards. 15 are in the same sector.

Shared director Other board Same sector

ARS Pharmaceuticals Inc. Same sector
via Laura Shawver
Arrowhead Pharmaceuticals Inc. Same sector
via Douglas S. Ingram
Bicara Therapeutics Inc. Same sector
via Claire Mazumdar
Jade Biosciences Inc. Same sector
via Habib J. Dable
Lexicon Pharmaceuticals Inc. Same sector
via Lonnel Coats
Maze Therapeutics Inc. Same sector
via Sekar Kathiresan
Mineralys Therapeutics Inc. Same sector
via Lonnel Coats
OPKO Health Inc. Same sector
via Alexis Borisy
Parabilis Medicines Inc. Same sector
via Alexis Borisy
PepGen Inc. Same sector
via Habib J. Dable
Revolution Medicines Inc. Same sector
via Alexis Borisy
Sarepta Therapeutics Inc. Same sector
via Douglas S. Ingram
SpyGlass Pharma Inc. Same sector
via Habib J. Dable
Tango Therapeutics Inc. Same sector
via Alexis Borisy
Tyra Biosciences Inc. Same sector
via Habib J. Dable

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $129,184,792; 39 sales by 5 insiders

Date	Insider	Transaction	Shares	Price	Value
Oct 28, 2026	Bergstrom Donald A Officer (President, R&D)	Open-market sale	−2,252	$18.62	$41,932
Oct 28, 2026	Catinazzo Thomas Officer (Chief Financial Officer)	Open-market sale	−1,469	$18.62	$27,353
Oct 28, 2026	Rahmer Peter Officer (See remarks)	Open-market sale	−753	$18.62	$14,021
Oct 7, 2026	Sanjiv Patel Director, Officer (President and CEO)	Open-market sale	−48,199	$18.10	$872,402
Oct 6, 2026	Catinazzo Thomas Officer (Chief Financial Officer)	Open-market sale	−17,511	$18.58	$325,354
Oct 6, 2026	Catinazzo Thomas Officer (Chief Financial Officer)	Open-market sale	−206	$19.26	$3,968
Sep 8, 2026	Bergstrom Donald A Officer (President, R&D)	Open-market sale	−8,530	$18.97	$161,814
Sep 8, 2026	Catinazzo Thomas Officer (Chief Financial Officer)	Open-market sale	−17,717	$18.94	$335,560
Sep 8, 2026	Sanjiv Patel Director, Officer (President and CEO)	Open-market sale	−48,199	$18.94	$912,889
Aug 26, 2026	Rahmer Peter Officer (See remarks)	Open-market sale	−4,508	$20.03	$90,295
Aug 25, 2026	SB INVESTMENT ADVISERS (UK) LTD 10% owner	Open-market sale	−6,000,000	$19.40	$116,400,000
Aug 17, 2026	Sanjiv Patel Director, Officer (President and CEO)	Open-market sale	−48,199	$20.33	$979,886
Aug 14, 2026	Catinazzo Thomas Officer (Chief Financial Officer)	Open-market sale	−17,717	$19.74	$349,734
Jul 28, 2026	Bergstrom Donald A Officer (President, R&D)	Open-market sale	−2,237	$18.61	$41,631
Jul 28, 2026	Catinazzo Thomas Officer (Chief Financial Officer)	Open-market sale	−1,459	$18.61	$27,152

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Relay Therapeutics Inc.

Who is the CEO of Relay Therapeutics Inc.?

Sanjiv Patel is Relay Therapeutics Inc.'s President and CEO.

How many directors are on Relay Therapeutics Inc.'s board?

Relay Therapeutics Inc.'s board has 11 directors: Alexis Borisy, Claire Mazumdar, Douglas S. Ingram, Habib J. Dable, Jami Rubin, Laura Shawver, Linda A. Hill, Lonnel Coats, Mark Murcko, Sanjiv Patel and 1 other.

Are Relay Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Relay Therapeutics Inc. insiders made no open-market purchases and sold $129.2 million of shares in 39 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Relay Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="relay-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.